期刊文献+

不同T分期乳腺癌患者分子分型与腋窝淋巴结转移的关系及其临床意义 被引量:20

Relationship between molecular typing and axillary lymph node metastasis in breast cancer patients with different T stages and its clinical significance
下载PDF
导出
摘要 目的:探讨不同肿瘤大小(T)分期乳腺癌患者病理分子分型与腋窝淋巴结转移的关系及其临床意义,指导前哨淋巴结活检术的应用,以避免腋窝淋巴结清扫术带来的术后并发症。方法:回顾性分析本科收治的临床资料完整、首次治疗为手术治疗、T在0~5cm的2 100例乳腺癌患者的临床病理特征及免疫组织化学检测结果,分析不同T分期乳腺癌患者分子分型与腋窝淋巴结转移的关系。比较不同分子亚型乳腺癌患者腋窝淋巴结转移率的差异,并对影响腋窝淋巴结转移的相关因素进行多因素Logistic回归分析。 Objective: To explore the relationship between molecular typing and axillary lymph node metastasis in the breast cancer patients with different tumor size (T) stages and its clinical significance, and to guide the application of sentinel lymph node biopsy to avoid the postoperative complications caused by axillary lymph node dissection. Methods: The clinicopathologic features and immunohistochemistry results of 2 100 breast cancer patients whose clinical data were complete with first treatment of surgical treatment and the T of 0- 5 cm were retrospectively analyzed. The relationship between various molecular subtyping of breast cancer and axillary lymph node metastasis was analyzed. The differences of axillary lymph node metastasis rates between various molecular subtypes were compared. The relevant {actors of axillary lymph node metastasis were analyzed by multivariate Logistic regression analysis. Results, The axillary lymph node metastasis rates among various molecular subtyes had obvious differences when the T of breast cancer were 1 cm〈T≤2 cm, 2 cm〈T≤3 cm, and 3 cm〈T≤4 cm (P〈0.05). In 0 cm〈T≤1cm, 1cm〈T≤2cm, 2 cm〈T≤3 cm, and 3 cm〈T≤4 cm, Luminal B type had the higher lymph node metastasis rate, and the rates were 40.00%, 29.41%, 50.00M, and 65.22%. When the tumor size was 4 cm〈T≤5 cm, the axillary lymph node metastasis rate of Her-2 type was the highest, about 75%. In all the breast cancer T grouping Triple-negative type had the lowest axillary lymph node metastasis rate. Her-2 overexpression was the independent risk factor for the metastasis of axillary lymph node. Oonclusion~ The characteristics of axillary lymph node metastasis are different in the breast cancer patients with various molecular subtypes. In the patients with Luminal B type and Her-2 type the sentinel lymph node needs to be more cautious. Her-2 overexpression is the independent risk factor for the metastasis of axillary lymph node. Molecular typing is an important complement to the traditional breast cancer pathological type and stage and it can further suggest the biological behavior of breast cancer and contribute to the development of individualized treatment.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2016年第1期144-148,共5页 Journal of Jilin University:Medicine Edition
基金 国家自然科学基金青年基金资助课题(81202078) 吉林省科技厅科研基金资助课题(YYZX201239)
关键词 乳腺肿瘤 分子分型 腋窝淋巴结转移 肿瘤大小 brest neoplasms molecular subtypes lymph node metastasis tumor size
  • 相关文献

参考文献16

  • 1Harris L,Fritsche H,Mennel R,et al.American Society of Clinical Oncology 2007update of recommendations for the use of tumor markers in breast cancer[J].Clin Oncol,2007,25(33):5287-5212.
  • 2Dent R,Trudeau M,Pritchard KI,et al.Triple-negative breast cancer:clinical features and patterns of recurrence[J].Clin Cancer Res,2007,13(15):4429-4434.
  • 3Haffty BG,Yang Q,Reiss M,et al.Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer[J].J Clin Oncol,2006,24(36):5652-5657.
  • 4Arana S,Vasquez-Del-Aguila J,Espinosa M,et al.Lymphatic mapping could not be impaired in the presence of breast carcinoma and coexisting small lymphocytic lymphoma[J].Am J Case Rep,2013,14:322-325.
  • 5Bhosale SJ,Kshirsagar AY,Sulhyan SR,et al.Matrixproducing meta-plastic breast carcinoma-a rare malignancy[J].Am J Case Rep,2013,14:213-215.
  • 6Testori A,Meroni S,Moscovici OC,et al.Surgical sentinel lymph node biop-sy in early breast cancer.Could it be avoided by performing a preoperative staging procedure?A pilot study[J].Med Sci Monit,2012,18(9):CR543-549.
  • 7Kim H,Dumont DJ.Molecular mechanisms in lymphangiogenesis model systems andimplications in human disease[J].Clin Genet,2003,64:282-292.
  • 8Silverstein MJ,Skiimer KA,Lomis TJ.Predictting axillary nodal positivity in 2282patienis with breast carcinoma[J].World J Surg,2001,25(6):767-772.
  • 9耿其荣,刘冬耕,史艳侠,向锦,吕跃.浸润性乳腺癌近似分子亚型的临床意义[J].中山大学学报(医学科学版),2009,30(4):458-462. 被引量:16
  • 10李振,周爱军,孙书峰,王洪勇,李涛,刁国庆,刘艳丽.乳腺癌四个分子亚型与腋窝淋巴结转移的相关性研究[J].北华大学学报(自然科学版),2015,16(3):338-341. 被引量:9

二级参考文献86

  • 1杨名添,戎铁华,黄植蕃,曾灿光,龙浩,傅剑华,林鹏,王欣,王思愚,王曦,唐军.可手术乳腺癌6263例临床分析[J].癌症,2005,24(3):327-331. 被引量:46
  • 2<乳腺癌HER2检测指南>编写组,霍临明.乳腺癌HER2检测指南[J].中华病理学杂志,2006,35(10):631-633. 被引量:164
  • 3张清媛,赵文辉,康欣梅.c-erbB1 c-erbB2和丝裂原活化蛋白激酶与乳腺癌三苯氧胺耐药的关系[J].中华肿瘤杂志,2006,28(11):826-830. 被引量:6
  • 4Pemu CM, Sφrlie T, Elsen MB, et al. Molecular portraits of human breast tumors. Nature, 2000, 406:747-752.
  • 5Kyndi M, SOrensen FB, Knudsen H, et al. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group. J Clin Oncol, 2008, 26 : 1419-1426.
  • 6Liedtke C, Mazouni C, Hess KR, et al. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. J Clin Oncol, 2008, 26:1275-1281.
  • 7Dent R, Trudeau M, Pritchard KI, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res, 2007, 13:4429-4434.
  • 8Ihemelandu CU, Leffall LD Jr, Dewitty RL, et al. Molecular breast cancer subtypes in premenopausal and postmenopausal African- American women: age-specific prevalence and survival. J Surg Res, 2007, 143:109-118.
  • 9Bauer KR, Brown M, Cress RD, et al. Descriptive analysis of estrogen receptor ( ER ) -negative, progesterone receptor ( PR ) -negative, and HER2-negative invasive breast cancer, the so-called triple- negative phenotype: a population-based study from the California cancer Registry. Cancer, 2007, 109 : 1721-1728.
  • 10Rakha EA, Ei-Sayed ME, Green AR, et al. Prognostic markers in triple-negative breast cancer. Cancer, 2007, 109:25-32.

共引文献78

同被引文献149

引证文献20

二级引证文献88

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部